![]() RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | |||
Founding Date | Founding Date 2009 | Founding Date 2015 | Founding Date 2001 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations South San Francisco, US HQ | Locations Lund, SE HQ |
Employees | Employees 3,9671% decrease | Employees 64 | Employees 1555% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 69.8 m | Valuation ($) 59 m |
Financial | |||
Net income | Net income N/A | Net income ($129.9m) (FY, 2024) | Net income (kr51.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 85.3m | Total funding raised $ 176m | Total funding raised N/A |

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View company